Author

Bill Zuercher

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Adam Schaenzer· 1 shared Dave Drewry· 1 shared Jeff Beczkiewicz· 1 shared John-Demian Sauer· 1 shared Kenneth Satyshur· 1 shared Martin Pavelka· 1 shared Nathan Teachout· 1 shared Nathan WlodarchakiD· 1 shared

Activity by Year

2017-2017 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Adam Schaenzer

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Repurposed kinase inhibitors and β-lactams as a novel therapy for antibiotic resistant bacteria

Nathan Wlodarchak, Nathan Teachout, Rebecca Procknow, Jeff Beczkiewicz, Adam Schaenzer, Kenneth Satyshur, Martin Pavelka, Bill Zuercher, Dave Drewry, John-Demian Sauer, Rob Striker

This study identifies kinase inhibitors that can be repurposed to combat antibiotic-resistant bacteria and shows they synergize with beta-lactams to enhance antimicrobial efficacy.

bioRxiv · Oct 7, 2017 · PreprintMicrobiology